Chime Biologics is a leading CDMO that enables its partners’ success in biologics. By leveraging our innovative R&D and manufacturing capabilities, we empower the entire biologics processes – from cell line development to commercial manufacturing – enabling customers to deliver affordable and accessible biologics that benefit patients worldwide.

Developer of stem cell production technology intended to create products using natural ingredients and technology. The company platform develops a variety of cosmetic products, striving to improve the treatment of incurable diseases, enabling medical professionals to promote human health using biotechnology.

ImmunAbs is a clinical-stage biotech company established by experts in global standard antibody therapeutics development.

Austrianova encapsulates living cells in tiny cellulose beads. The beads act as a microenvironment for living cells, allowing them to be metabolically active and divide.

Developer of monoclonal antibody therapeutics to treat cancer and infectious diseases. The company has developed a fully human proprietary mAb technology platform INABLR.

Developed corporate Wellness Platform using metabolic markers to provide bio hacks and nudges to employees to reduce stress and improve productivity.

Umami Meats is developing delicious, affordable, sustainable cultured seafood based on a proprietary, low-cost growth serum.